Nephrocare Health Services Latest Share Price (NEPHROPLUS)
TODAY IN ONE LINE
NEPHROPLUS rose 1.5%, in line with Nifty's 0.5% move, supported by recent strong earnings.
With a market cap of ₹6,990.74 Cr., it trades at a P/E of 89.97. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Nephrocare Health Services flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 21.2% and Profit up 22.1%
- ●High Capital EfficiencyROCE of 15.5% indicating pricing power
- ●Healthy Operating MarginsOPM is structurally strong at 22.4%
- ●High Promoter HoldingPromoters hold 63.9% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.07x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 9.1%
- ●Expensive ValuationTrading at a high P/E ratio of 88.6x
Latest Nephrocare Health Services News
What changed recently?
Recent events, corporate actions, and announcements.
Nephrocare Health Services Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Nephrocare Health Services Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Nephrocare Health Services Ltd trades at a P/E of 89.97× and P/B of 6.19×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Nephrocare Health Services Ltd technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Nephrocare Health Services Ltd — derived from the latest tape, not yesterday's close.
Nephrocare Health Services Ltd last traded at ₹697.35 with an intraday range of ₹680–₹707 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹697.35| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 763.57 | +66.22 | +9.50% |
| R3 | 736.57 | +39.22 | +5.62% |
| R2 | 721.78 | +24.43 | +3.50% |
| R1 | 709.57 | +12.22 | +1.75% |
| PIVOT | 694.78 | -2.57 | -0.37% |
| CURRENT | 697.35 | — | — |
| S1 | 682.57 | -14.78 | -2.12% |
| S2 | 667.78 | -29.57 | -4.24% |
| S3 | 655.57 | -41.78 | -5.99% |
| S4 | 628.57 | -68.78 | -9.86% |
NEPHROPLUS is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹682.2–₹695
Trading Inside opening range
Nephrocare Health Services Ltd financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Nephrocare Health Services Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.
Nephrocare Health Services Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹6,990.74 Cr. and reported EPS of ₹7.66.
| Metric | — | Mar 2026 |
|---|---|---|
| Revenue from Operations | — | 999 |
| Other Income | — | 25 |
| Total Income | — | 1,023 |
| — | 227 | |
| Gross ProfitDerived | — | 772 |
| Gross Margin %Derived | — | 77.29% |
| — | 545 | |
| EBITDA (Operating Profit)Derived | — | 227 |
| OPM %Derived | — | 22.72% |
| — | 151 | |
| Profit Before Tax (PBT) | — | 101 |
| — | 21 | |
| Effective Tax %Derived | — | 20.52% |
| Total Profit for Period | — | 77 |
| Net Profit (Owner's PAT)Derived | — | 77 |
| Net Profit Margin %Derived | — | 7.69% |
| Earnings Per Share (EPS ₹) | — | 7.66 |
| Diluted Shares Outstanding (Cr) | — | 10 |
| Share of Profit from Associates/JVs | — | -3 |
| Other Comprehensive Income (Net of Tax) | — | 19 |
| Total Expenses (incl. D&A & Interest) | — | 923 |
| Material Cost % of RevenueDerived | — | 22.71% |
| Employee Cost % of RevenueDerived | — | 17.20% |
| Other Cost % of RevenueDerived | — | 37.37% |
| Interest Coverage (x)Derived | — | 2.26x |
| Period | Mar 2026 | Trend |
|---|---|---|
| Revenue from Operations | 999 | |
| Other Income | 25 | |
| Total Income | 1,023 | |
227 | ||
| Gross ProfitDerived | 772 | |
| Gross Margin %Derived | 77.29% | |
545 | ||
| EBITDA (Operating Profit)Derived | 227 | |
| OPM %Derived | 22.72% | |
151 | ||
| Profit Before Tax (PBT) | 101 | |
21 | ||
| Effective Tax %Derived | 20.52% | |
| Total Profit for Period | 77 | |
| Net Profit (Owner's PAT)Derived | 77 | |
| Net Profit Margin %Derived | 7.69% | |
| Earnings Per Share (EPS ₹) | 7.66 | |
| Diluted Shares Outstanding (Cr) | 10 | |
| Share of Profit from Associates/JVs | -3 | |
| Other Comprehensive Income (Net of Tax) | 19 | |
| Total Expenses (incl. D&A & Interest) | 923 | |
| Material Cost % of RevenueDerived | 22.71% | |
| Employee Cost % of RevenueDerived | 17.20% | |
| Other Cost % of RevenueDerived | 37.37% | |
| Interest Coverage (x)Derived | 2.26x |
Nephrocare Health Services segment analysis : revenue and profit mix.
Disclosed business segments at Nephrocare Health Services with their share of revenue and profit, switchable between consolidated and standalone reporting.
Nephrocare Health Services discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Nephrocare Health Services Ltd.
Our AI distills the core fundamental drivers supporting Nephrocare Health Services Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 117 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Nephrocare Health Services Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Nephrocare Health Services Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Nephrocare Health Services Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Nephrocare Health Services Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Nephrocare Health Services Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Nephrocare Health Services Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Nephrocare Health Services Ltd stood at 57.0% of traded volume, against a 20-day average of 56.5%.
Nephrocare Health Services announcements: results, concalls, ratings, M&A.
Filings Nephrocare Health Services sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Nephrocare Health Services files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 67 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Nephrocare Health Services Limited has informed the Exchange about Transcript
Agreements
Nephrocare Health Services Limited has informed the Exchange about Agreements
Shareholders meeting
Nephrocare Health Services Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 12, 2026. Further,…
Analysts/Institutional Investor Meet/Con. Call Updates
Nephrocare Health Services Limited has informed the Exchange about Schedule of meet
Agreements
Nephrocare Health Services Limited has informed the Exchange about Agreements
Investor decks & rating reports.
Nephrocare Health Services dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Nephrocare Health Services has declared, sequenced by announce and record date.
Nephrocare Health Services corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Nephrocare Health Services Ltd: business, sector, key facts.
What Nephrocare Health Services Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Nephrocare Health Services Ltd is a listed Indian equity, listed as NSE: NEPHROPLUS, BSE: 544647.
Nephrocare Health Services Ltd
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- Anlon Healthcare (AHCL) Share PricePeer
- Amanta Healthcare (AMANTA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Nephrocare Health Services Ltd (NEPHROPLUS).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Nephrocare Health Services Ltd (NEPHROPLUS)?
The current share price of Nephrocare Health Services Ltd (NEPHROPLUS) is ₹697.35. Today, the stock has gained by ₹10.10 (1.47%), trading in a range of ₹680.00 to ₹707.00. The stock opened at ₹695.00 with a trading volume of 1,45,755 shares.
02Is Nephrocare Health Services Ltd stock a good investment for long-term?
Nephrocare Health Services Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹6,990.74 Cr., P/E ratio of 89.97, ROE of 9.06%, and ROCE of 15.5%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Nephrocare Health Services Ltd stock?
The 52-week high price of Nephrocare Health Services Ltd (NEPHROPLUS) is ₹769.75, while the 52-week low is ₹446.00. Currently trading at ₹697.35, the stock is 56.36% above its 52-week low and 9.41% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Nephrocare Health Services Ltd stock at the current price?
Whether to buy Nephrocare Health Services Ltd stock at ₹697.35 depends on multiple factors. The stock is currently trading with a P/E ratio of 89.97 and P/B ratio of 6.19. Today's performance shows a gain of 1.47%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Nephrocare Health Services Ltd and when is the next dividend?
Nephrocare Health Services Ltd offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹697.35, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Nephrocare Health Services Ltd?
Nephrocare Health Services Ltd's key financial metrics include: P/E Ratio: 89.97, P/B Ratio: 6.19, ROE: 9.06%, ROCE: 15.5%, Dividend Yield: 0%, EPS: ₹7.66, Book Value: ₹111.00, and Debt-to-Equity: 0.07. The company's market cap stands at ₹6,990.74 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Nephrocare Health Services Ltd stock performing today in the market?
Nephrocare Health Services Ltd stock opened at ₹695.00 and is currently trading at ₹697.35, showing a gain of ₹10.10 (1.47%). The intraday high is ₹707.00 and low is ₹680.00. The trading volume stands at 1,45,755 shares, indicating moderate market participation today.
08What is the P/E ratio of Nephrocare Health Services Ltd and what does it indicate?
Nephrocare Health Services Ltd has a Price-to-Earnings (P/E) ratio of 89.97, which means investors are willing to pay 89.97 for every ₹1 of earnings. With an EPS of ₹7.66, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Nephrocare Health Services Ltd (NEPHROPLUS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.